- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 30 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 6 residues within 4Å:- Chain A: V.104, N.106, N.118, Y.135, L.137, D.290
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.135
NAG-NAG-BMA.16: 6 residues within 4Å:- Chain G: V.104, N.106, N.118, Y.135, L.137, D.290
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:Y.135
NAG-NAG-BMA.30: 6 residues within 4Å:- Chain M: V.104, N.106, N.118, Y.135, L.137, D.290
1 PLIP interactions:1 interactions with chain M- Hydrophobic interactions: M:Y.135
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.5: 11 residues within 4Å:- Chain A: S.179, E.181, P.182, V.224, L.231, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.11
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:V.414
NAG-NAG-BMA-MAN-MAN-MAN.19: 11 residues within 4Å:- Chain G: S.179, E.181, P.182, V.224, L.231, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.25
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:V.414
NAG-NAG-BMA-MAN-MAN-MAN.33: 11 residues within 4Å:- Chain M: S.179, E.181, P.182, V.224, L.231, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.39
1 PLIP interactions:1 interactions with chain M- Hydrogen bonds: M:V.414
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.6: 13 residues within 4Å:- Chain A: N.246, T.248, N.249
- Chain B: G.107, F.108, A.110
- Chain C: D.30, S.32, Y.49, S.53, R.54, I.56, Y.92
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain C- Hydrogen bonds: B:G.107, C:S.53, C:S.53, C:D.30, C:S.32, B:A.110
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.20: 13 residues within 4Å:- Chain G: N.246, T.248, N.249
- Chain H: G.107, F.108, A.110
- Chain I: D.30, S.32, Y.49, S.53, R.54, I.56, Y.92
3 PLIP interactions:1 interactions with chain H, 2 interactions with chain I- Hydrogen bonds: H:G.107, I:S.53, I:S.53, I:D.30, I:S.32, H:A.110
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN.34: 13 residues within 4Å:- Chain M: N.246, T.248, N.249
- Chain N: G.107, F.108, A.110
- Chain O: D.30, S.32, Y.49, S.53, R.54, I.56, Y.92
3 PLIP interactions:1 interactions with chain N, 2 interactions with chain O- Hydrogen bonds: N:G.107, O:S.53, O:S.53, N:A.110, O:D.30, O:S.32
- 3 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-FUC.14: 6 residues within 4Å:- Chain D: P.98, N.100, S.102, W.103, Y.127, L.134
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:P.98, D:Y.127
NAG-FUC.28: 6 residues within 4Å:- Chain J: P.98, N.100, S.102, W.103, Y.127, L.134
1 PLIP interactions:1 interactions with chain J- Hydrophobic interactions: J:P.98, J:Y.127
NAG-FUC.42: 6 residues within 4Å:- Chain P: P.98, N.100, S.102, W.103, Y.127, L.134
1 PLIP interactions:1 interactions with chain P- Hydrophobic interactions: P:P.98, P:Y.127
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.43: 4 residues within 4Å:- Chain A: R.162, N.167
- Chain G: E.126, R.278
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain A: K.304, N.308, W.364
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain A: N.103, T.105, K.117
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain A: N.107
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain D: N.107, S.109
- Chain E: T.56
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain D: E.123, N.126
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain G: R.162, N.167
- Chain M: E.126, R.278
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain G: K.304, N.308, W.364
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain G: N.103, T.105, K.117
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain G: N.107
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain J: N.107, S.109
- Chain K: T.56
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain J: E.123, N.126
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain A: E.126, R.278
- Chain M: R.162, N.167
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain M: K.304, N.308, W.364
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain M: N.103, T.105, K.117
Ligand excluded by PLIPNAG.58: 1 residues within 4Å:- Chain M: N.107
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain P: N.107, S.109
- Chain Q: T.56
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain P: E.123, N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, C.A. et al., Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies. Cell Rep (2021)
- Release Date
- 2021-09-15
- Peptides
- Envelope glycoprotein gp120: AGM
VRC40.01 Fab Heavy Chain: BHN
VRC40.01 Fab Kappa Light Chain: CIO
Envelope glycoprotein gp41: DJP
RM19R Fab Kappa Light Chain: EKQ
RM19R Fab Heavy Chain: FLR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AG
EM
FB
HH
ON
PC
LI
QO
RD
BJ
GP
IE
DK
MQ
NF
CL
JR
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 30 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, C.A. et al., Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies. Cell Rep (2021)
- Release Date
- 2021-09-15
- Peptides
- Envelope glycoprotein gp120: AGM
VRC40.01 Fab Heavy Chain: BHN
VRC40.01 Fab Kappa Light Chain: CIO
Envelope glycoprotein gp41: DJP
RM19R Fab Kappa Light Chain: EKQ
RM19R Fab Heavy Chain: FLR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AG
EM
FB
HH
ON
PC
LI
QO
RD
BJ
GP
IE
DK
MQ
NF
CL
JR
K